Topamax is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Topiramate.
Product ID | 50458-641_007c7ba9-3103-4238-9524-a9421607912d |
NDC | 50458-641 |
Product Type | Human Prescription Drug |
Proprietary Name | Topamax |
Generic Name | Topiramate |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 1997-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020505 |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | TOPIRAMATE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1997-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020505 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1997-01-01 |
Ingredient | Strength |
---|---|
TOPIRAMATE | 100 mg/1 |
SPL SET ID: | 21628112-0c47-11df-95b3-498d55d89593 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
70518-1393 | Topamax | Topamax |
21695-128 | Topamax | Topamax |
21695-130 | Topamax | Topamax |
21695-129 | Topamax | Topamax |
50458-647 | Topamax | Topamax |
50458-645 | Topamax | Topamax |
50458-642 | Topamax | Topamax |
50458-641 | Topamax | Topamax |
50458-639 | Topamax | Topamax |
50458-640 | Topamax | Topamax |
55289-433 | Topamax | Topamax |
61919-189 | TOPAMAX | TOPAMAX |
70518-2165 | Topamax | Topamax |
70518-2753 | Topamax | Topamax |
80425-0092 | Topamax | Topamax |
0245-1071 | QUDEXY | Topiramate |
0245-1072 | QUDEXY | Topiramate |
0245-1073 | QUDEXY | Topiramate |
0245-1074 | QUDEXY | Topiramate |
0245-1075 | QUDEXY | Topiramate |
0093-7335 | Topiramate | Topiramate |
0093-7336 | Topiramate | Topiramate |
0615-7562 | Topiramate | Topiramate |
0615-7563 | Topiramate | Topiramate |
0615-7564 | Topiramate | Topiramate |
0615-7565 | Topiramate | Topiramate |
0615-8138 | Topiramate | Topiramate |
0615-8139 | Topiramate | Topiramate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TOPAMAX 85391764 4128458 Live/Registered |
JOHNSON & JOHNSON 2011-08-08 |
TOPAMAX 78278329 2968496 Dead/Cancelled |
Johnson & Johnson 2003-07-24 |
TOPAMAX 74384910 1909122 Live/Registered |
JOHNSON & JOHNSON 1993-04-23 |